$BHRT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in U.S. Stem Cell, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in U.S. Stem Cell, Inc.. Get notifications about new insider transactions in U.S. Stem Cell, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 20 2019 | BHRT | U.S. Stem Cell, In ... | TOMAS MIKE | President & CEO | Option Exercise | A | 0.00 | 1,500,000 | 7,350 | 81,541,284 | |
| Dec 20 2019 | BHRT | U.S. Stem Cell, In ... | TOMAS MIKE | President & CEO | Option Exercise | A | 0.01 | 20,000,000 | 114,000 | 80,041,284 | |
| Dec 20 2019 | BHRT | U.S. Stem Cell, In ... | Knutson Gregory | Director | Option Exercise | A | 0.00 | 1,500,000 | 7,350 | 3,625,000 | |
| Dec 20 2019 | BHRT | U.S. Stem Cell, In ... | Anderson Sheldon T. | Director | Option Exercise | A | 0.00 | 1,500,000 | 7,350 | 6,001,400 | |
| Dec 20 2019 | BHRT | U.S. Stem Cell, In ... | Borman Mark P | Director | Option Exercise | A | 0.00 | 1,500,000 | 7,350 | 6,002,810 | |
| Dec 07 2018 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Option Exercise | A | 0.03 | 1,500,000 | 37,650 | 4,503,087 | |
| Dec 07 2018 | BHRT | U.S. Stem Cell, In ... | Knutson Gregory | Director | Option Exercise | A | 0.03 | 1,500,000 | 37,650 | 2,125,000 | |
| Dec 07 2018 | BHRT | U.S. Stem Cell, In ... | Comella Kristin C | Chief Science Offic ... | Option Exercise | A | 0.03 | 1,500,000 | 37,650 | 32,097,746 | |
| Dec 07 2018 | BHRT | U.S. Stem Cell, In ... | Borman Mark P | Director | Option Exercise | A | 0.03 | 1,500,000 | 37,650 | 4,502,810 | |
| Dec 07 2018 | BHRT | U.S. Stem Cell, In ... | Anderson Sheldon T. | Director | Option Exercise | A | 0.03 | 1,500,000 | 37,650 | 4,501,400 | |
| Oct 26 2018 | BHRT | U.S. Stem Cell, In ... | Borman Mark P | Director | Buy | J | 0.03 | 526,918 | 14,227 | 526,942 | 24 to 526.9 K (+2,195,491.67 %) |
| May 18 2018 | BHRT | U.S. Stem Cell, In ... | TOMAS MIKE | CEO & President | Option Exercise | A | 0.05 | 20,000,000 | 1,072,000 | 58,541,284 | |
| May 18 2018 | BHRT | U.S. Stem Cell, In ... | Comella Kristin C | Chief Scientific Of ... | Option Exercise | A | 0.05 | 10,000,000 | 536,000 | 30,697,746 | |
| Sep 01 2017 | BHRT | U.S. Stem Cell, In ... | Comella Kristin C | Chief Scientific Of ... | Option Exercise | A | 0.03 | 1,500,000 | 48,900 | 20,697,746 | |
| Sep 01 2017 | BHRT | U.S. Stem Cell, In ... | Comella Kristin C | Chief Scientific Of ... | Option Exercise | A | 0.03 | 7,500,000 | 244,500 | 19,197,746 | |
| Sep 01 2017 | BHRT | U.S. Stem Cell, In ... | TOMAS MIKE | CEO & President | Option Exercise | A | 0.03 | 1,500,000 | 48,900 | 38,341,284 | |
| Sep 01 2017 | BHRT | U.S. Stem Cell, In ... | TOMAS MIKE | CEO & President | Option Exercise | A | 0.03 | 15,000,000 | 489,000 | 36,841,284 | |
| Aug 25 2017 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Option Exercise | A | 0.03 | 1,500,000 | 48,900 | 3,003,087 | |
| Aug 25 2017 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | P | 0.03 | 1,799,614 | 49,849 | 2,088,818 | 289.2 K to 2.1 M (+622.26 %) |
| Aug 25 2017 | BHRT | U.S. Stem Cell, In ... | Borman Mark P | Director | Option Exercise | A | 0.03 | 1,500,000 | 48,900 | 3,002,810 | |
| Aug 25 2017 | BHRT | U.S. Stem Cell, In ... | Anderson Sheldon T. | Director | Option Exercise | A | 0.03 | 1,500,000 | 48,900 | 3,001,400 | |
| Mar 31 2017 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | M | 0.03 | 1,748,947 | 58,590 | 3,023,782 | 1.3 M to 3 M (+137.19 %) |
| Mar 17 2017 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | P | 0.02 | 1,200,000 | 24,000 | 1,274,835 | 74.8 K to 1.3 M (+1,603.53 %) |
| Feb 17 2017 | BHRT | U.S. Stem Cell, In ... | TOMAS MIKE | CEO & President | Option Exercise | A | 0.00 | 10,000,000 | 43,000 | 21,841,284 | |
| Feb 17 2017 | BHRT | U.S. Stem Cell, In ... | Comella Kristin C | Chief Scientific Of ... | Option Exercise | A | 0.00 | 5,000,000 | 21,500 | 11,697,748 | |
| Sep 23 2016 | BHRT | U.S. Stem Cell, In ... | TOMAS MIKE | CEO & President | Option Exercise | A | 0.02 | 1,500,000 | 29,400 | 11,841,284 | |
| Sep 23 2016 | BHRT | U.S. Stem Cell, In ... | TOMAS MIKE | CEO & President | Option Exercise | A | 0.02 | 10,000,000 | 196,000 | 10,341,284 | |
| Sep 23 2016 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Option Exercise | A | 0.02 | 1,500,000 | 29,400 | 1,503,087 | |
| Sep 23 2016 | BHRT | U.S. Stem Cell, In ... | Comella Kristin C | Chief Scientific Of ... | Option Exercise | A | 0.02 | 1,500,000 | 29,400 | 6,697,748 | |
| Sep 23 2016 | BHRT | U.S. Stem Cell, In ... | Comella Kristin C | Chief Scientific Of ... | Option Exercise | A | 0.02 | 5,000,000 | 98,000 | 5,197,748 | |
| Sep 23 2016 | BHRT | U.S. Stem Cell, In ... | Borman Mark P | Director | Option Exercise | A | 0.02 | 1,500,000 | 29,400 | 1,502,810 | |
| Sep 23 2016 | BHRT | U.S. Stem Cell, In ... | Anderson Sheldon T. | Director | Option Exercise | A | 0.02 | 1,500,000 | 29,400 | 1,501,400 | |
| Feb 16 2016 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | C | 1.46 | 14,606 | 21,325 | 74,833 | 60.2 K to 74.8 K (+24.25 %) |
| Jan 04 2016 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | C | 0.00 | 300 | 0 | 64,670 | 64.4 K to 64.7 K (+0.47 %) |
| Jan 04 2016 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | C | 0.00 | 1,850 | 0 | 64,370 | 62.5 K to 64.4 K (+2.96 %) |
| Jan 04 2016 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | C | 0.00 | 900 | 0 | 62,520 | 61.6 K to 62.5 K (+1.46 %) |
| Jan 04 2016 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | C | 0.00 | 2,150 | 0 | 61,620 | 59.5 K to 61.6 K (+3.62 %) |
| Dec 28 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | C | 0.00 | 600 | 0 | 59,470 | 58.9 K to 59.5 K (+1.02 %) |
| Dec 28 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | C | 0.00 | 1,150 | 0 | 58,870 | 57.7 K to 58.9 K (+1.99 %) |
| Dec 28 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | C | 0.00 | 5,775 | 0 | 57,720 | 51.9 K to 57.7 K (+11.12 %) |
| Dec 21 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | C | 0.00 | 1,300 | 0 | 51,945 | 50.6 K to 51.9 K (+2.57 %) |
| Dec 21 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | C | 0.00 | 950 | 0 | 50,645 | 49.7 K to 50.6 K (+1.91 %) |
| Dec 21 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | C | 0.00 | 4,250 | 0 | 49,695 | 45.4 K to 49.7 K (+9.35 %) |
| Dec 21 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | C | 0.00 | 400 | 0 | 45,445 | 45 K to 45.4 K (+0.89 %) |
| Dec 21 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | C | 0.00 | 1,250 | 0 | 45,045 | 43.8 K to 45 K (+2.85 %) |
| Dec 21 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | C | 0.75 | 146 | 109 | 43,795 | 43.6 K to 43.8 K (+0.33 %) |
| Dec 21 2015 | BHRT | U.S. Stem Cell, In ... | TOMAS MIKE | CEO & President | Buy | C | 0.00 | 1,514 | 0 | 9,193 | 7.7 K to 9.2 K (+19.72 %) |
| Dec 07 2015 | BHRT | U.S. Stem Cell, In ... | TOMAS MIKE | CEO & President | Buy | C | 0.00 | 600 | 0 | 8,279 | 7.7 K to 8.3 K (+7.81 %) |
| Dec 07 2015 | BHRT | U.S. Stem Cell, In ... | TOMAS MIKE | CEO & President | Buy | C | 0.00 | 1,100 | 0 | 7,679 | 6.6 K to 7.7 K (+16.72 %) |
| Dec 01 2015 | BHRT | U.S. Stem Cell, In ... | TOMAS MIKE | CEO & President | Option Exercise | A | 1.71 | 291,885 | 499,123 | 342,284 | |
| Dec 01 2015 | BHRT | U.S. Stem Cell, In ... | TOMAS MIKE | CEO & President | Option Exercise | A | 6.24 | 10,000 | 62,400 | 50,399 | |
| Dec 01 2015 | BHRT | U.S. Stem Cell, In ... | Comella Kristin C | Chief Scientific Of ... | Option Exercise | A | 1.71 | 175,131 | 299,474 | 192,762 | |
| Dec 01 2015 | BHRT | U.S. Stem Cell, In ... | Comella Kristin C | Chief Scientific Of ... | Option Exercise | A | 6.24 | 5,000 | 31,200 | 17,631 | |
| Nov 23 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | C | 1.69 | 55 | 93 | 5,226 | 5.2 K to 5.2 K (+1.06 %) |
| Nov 23 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | C | 1.69 | 219 | 370 | 43,649 | 43.4 K to 43.6 K (+0.50 %) |
| Nov 16 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | P | 0.00 | 825 | 0 | 43,430 | 42.6 K to 43.4 K (+1.94 %) |
| Nov 13 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | P | 1.40 | 1,000 | 1,400 | 42,605 | 41.6 K to 42.6 K (+2.40 %) |
| Nov 13 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | P | 0.00 | 1,115 | 0 | 41,605 | 40.5 K to 41.6 K (+2.75 %) |
| Nov 09 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | P | 0.00 | 90 | 0 | 40,490 | 40.4 K to 40.5 K (+0.22 %) |
| Nov 09 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | P | 0.00 | 245 | 0 | 40,395 | 40.2 K to 40.4 K (+0.61 %) |
| Nov 09 2015 | BHRT | U.S. Stem Cell, In ... | AHN SAMUEL S | Director | Buy | P | 0.00 | 411 | 0 | 42,806 | 42.4 K to 42.8 K (+0.97 %) |
| Nov 09 2015 | BHRT | U.S. Stem Cell, In ... | AHN SAMUEL S | Director | Buy | P | 0.00 | 2,425 | 0 | 42,395 | 40 K to 42.4 K (+6.07 %) |
| Nov 06 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | P | 0.00 | 226 | 0 | 40,150 | 39.9 K to 40.2 K (+0.57 %) |
| Nov 06 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | P | 0.00 | 8,740 | 0 | 39,924 | 31.2 K to 39.9 K (+28.03 %) |
| Nov 06 2015 | BHRT | U.S. Stem Cell, In ... | AHN SAMUEL S | Director | Buy | P | 0.00 | 295 | 0 | 39,970 | 39.7 K to 40 K (+0.74 %) |
| Nov 06 2015 | BHRT | U.S. Stem Cell, In ... | AHN SAMUEL S | Director | Buy | P | 0.00 | 2,940 | 0 | 39,675 | 36.7 K to 39.7 K (+8.00 %) |
| Nov 02 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | P | 0.00 | 310,000 | 0 | 31,183,903 | 30.9 M to 31.2 M (+1.00 %) |
| Oct 29 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | P | 0.00 | 3,019,998 | 0 | 30,873,903 | 27.9 M to 30.9 M (+10.84 %) |
| Oct 29 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | P | 0.00 | 400,000 | 480 | 27,853,905 | 27.5 M to 27.9 M (+1.46 %) |
| Oct 21 2015 | BHRT | U.S. Stem Cell, In ... | AHN SAMUEL S | Director | Buy | P | 0.00 | 2,999,997 | 0 | 36,734,394 | 33.7 M to 36.7 M (+8.89 %) |
| Oct 19 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | P | 0.00 | 1,099,999 | 1,430 | 28,553,904 | 27.5 M to 28.6 M (+4.01 %) |
| Oct 19 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | P | 0.00 | 999,999 | 0 | 27,453,905 | 26.5 M to 27.5 M (+3.78 %) |
| Oct 13 2015 | BHRT | U.S. Stem Cell, In ... | AHN SAMUEL S | Director | Buy | P | 0.00 | 2,499,998 | 0 | 33,734,397 | 31.2 M to 33.7 M (+8.00 %) |
| Oct 13 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | P | 0.00 | 700,000 | 910 | 26,453,906 | 25.8 M to 26.5 M (+2.72 %) |
| Oct 07 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | P | 0.00 | 199,500 | 279 | 25,753,906 | 25.6 M to 25.8 M (+0.78 %) |
| Oct 07 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | P | 0.00 | 188,000 | 0 | 25,554,406 | 25.4 M to 25.6 M (+0.74 %) |
| Oct 05 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | P | 0.00 | 1,999,998 | 0 | 25,366,404 | 23.4 M to 25.4 M (+8.56 %) |
| Oct 05 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | P | 0.00 | 2,499,998 | 0 | 23,366,406 | 20.9 M to 23.4 M (+11.98 %) |
| Oct 01 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | P | 0.00 | 750,000 | 0 | 20,866,408 | 20.1 M to 20.9 M (+3.73 %) |
| Oct 01 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | P | 0.00 | 4,099,996 | 0 | 20,116,408 | 16 M to 20.1 M (+25.60 %) |
| May 26 2015 | BHRT | U.S. Stem Cell, In ... | AHN SAMUEL S | Director | Buy | P | 0.01 | 2,994,012 | 20,060 | 31,234,399 | 28.2 M to 31.2 M (+10.60 %) |
| May 20 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | P | 0.01 | 2,873,564 | 20,115 | 16,016,412 | 13.1 M to 16 M (+21.86 %) |
| Feb 13 2015 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Option Exercise | A | 0.01 | 1,000,000 | 11,200 | 3,723,529 | |
| Feb 13 2015 | BHRT | U.S. Stem Cell, In ... | Anderson Sheldon T. | Director | Option Exercise | A | 0.01 | 1,000,000 | 11,200 | 4,140,994 | |
| Feb 13 2015 | BHRT | U.S. Stem Cell, In ... | Borman Mark P | Director | Option Exercise | A | 0.01 | 1,000,000 | 11,200 | 2,810,000 | |
| Feb 13 2015 | BHRT | U.S. Stem Cell, In ... | AHN SAMUEL S | Director | Option Exercise | A | 0.01 | 1,000,000 | 11,200 | 12,657,750 | |
| Feb 13 2015 | BHRT | U.S. Stem Cell, In ... | Hart Charles A | Director | Option Exercise | A | 0.01 | 1,000,000 | 11,200 | 8,871,430 | |
| Feb 13 2015 | BHRT | U.S. Stem Cell, In ... | Comella Kristin C | Chief Science Offic ... | Option Exercise | A | 0.01 | 1,000,000 | 11,200 | 17,626,286 | |
| Feb 13 2015 | BHRT | U.S. Stem Cell, In ... | TOMAS MIKE | CEO & President | Option Exercise | A | 0.01 | 1,000,000 | 11,200 | 40,398,487 | |
| Nov 18 2014 | BHRT | U.S. Stem Cell, In ... | Anderson Sheldon T. | Director | Option Exercise | A | 0.03 | 400,000 | 10,040 | 3,140,994 | |
| Nov 18 2014 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Option Exercise | A | 0.03 | 400,000 | 10,040 | 2,723,529 | |
| Nov 18 2014 | BHRT | U.S. Stem Cell, In ... | Borman Mark P | Director | Option Exercise | A | 0.03 | 400,000 | 10,040 | 1,810,000 | |
| Nov 18 2014 | BHRT | U.S. Stem Cell, In ... | AHN SAMUEL S | Director | Option Exercise | A | 0.03 | 400,000 | 10,040 | 11,657,750 | |
| Nov 18 2014 | BHRT | U.S. Stem Cell, In ... | Hart Charles A | Director | Option Exercise | A | 0.03 | 400,000 | 10,080 | 7,871,430 | |
| Nov 18 2014 | BHRT | U.S. Stem Cell, In ... | Comella Kristin C | Chief Science Offic ... | Option Exercise | A | 0.03 | 400,000 | 10,080 | 16,626,286 | |
| Nov 18 2014 | BHRT | U.S. Stem Cell, In ... | TOMAS MIKE | CEO & President | Option Exercise | A | 0.03 | 400,000 | 10,080 | 39,398,487 | |
| Aug 13 2014 | BHRT | U.S. Stem Cell, In ... | TOMAS MIKE | CEO & President | Option Exercise | A | 0.03 | 10,000,000 | 269,000 | 38,998,487 | |
| Aug 13 2014 | BHRT | U.S. Stem Cell, In ... | Comella Kristin C | Chief Science Offic ... | Option Exercise | A | 0.03 | 5,000,000 | 134,500 | 16,262,286 | |
| Aug 06 2014 | BHRT | U.S. Stem Cell, In ... | Hart Charles A | Director | Buy | J | 0.04 | 44,328 | 1,773 | 9,194,422 | 9.2 M to 9.2 M (+0.48 %) |
| Jun 24 2014 | BHRT | U.S. Stem Cell, In ... | AHN SAMUEL S | Director | Buy | J | 0.04 | 5,378,296 | 215,132 | 28,240,387 | 22.9 M to 28.2 M (+23.52 %) |
| Jun 24 2014 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | J | 0.04 | 5,170,918 | 206,837 | 19,113,766 | 13.9 M to 19.1 M (+37.09 %) |
| Jun 24 2014 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | J | 0.04 | 5,170,919 | 206,837 | 13,942,848 | 8.8 M to 13.9 M (+58.95 %) |
| Jun 03 2014 | BHRT | U.S. Stem Cell, In ... | TOMAS MIKE | CEO & President | Option Exercise | A | 0.03 | 4,298,487 | 116,919 | 28,998,487 | |
| Apr 15 2014 | BHRT | U.S. Stem Cell, In ... | Anderson Sheldon T. | Director | Option Exercise | A | 0.02 | 800,000 | 15,200 | 2,740,994 | |
| Apr 15 2014 | BHRT | U.S. Stem Cell, In ... | TOMAS MIKE | CEO & President | Option Exercise | A | 0.02 | 10,000,000 | 190,000 | 24,700,000 | |
| Apr 15 2014 | BHRT | U.S. Stem Cell, In ... | TOMAS MIKE | CEO & President | Option Exercise | A | 0.02 | 800,000 | 15,200 | 14,700,000 | |
| Apr 15 2014 | BHRT | U.S. Stem Cell, In ... | AHN SAMUEL S | Director | Option Exercise | A | 0.02 | 800,000 | 15,200 | 19,019,716 | |
| Apr 15 2014 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Option Exercise | A | 0.02 | 800,000 | 15,200 | 2,363,529 | |
| Apr 15 2014 | BHRT | U.S. Stem Cell, In ... | Borman Mark P | Director | Option Exercise | A | 0.02 | 800,000 | 15,200 | 1,410,000 | |
| Apr 15 2014 | BHRT | U.S. Stem Cell, In ... | Hart Charles A | Director | Option Exercise | A | 0.02 | 800,000 | 15,200 | 7,312,440 | |
| Apr 15 2014 | BHRT | U.S. Stem Cell, In ... | Comella Kristin C | Chief Science Offic ... | Option Exercise | A | 0.02 | 5,000,000 | 95,000 | 10,962,288 | |
| Apr 15 2014 | BHRT | U.S. Stem Cell, In ... | Comella Kristin C | Chief Science Offic ... | Option Exercise | A | 0.02 | 400,000 | 7,600 | 5,962,288 | |
| Mar 14 2014 | BHRT | U.S. Stem Cell, In ... | AHN SAMUEL S | Director | Option Exercise | A | 0.02 | 400,000 | 8,000 | 11,019,716 | |
| Mar 14 2014 | BHRT | U.S. Stem Cell, In ... | AHN SAMUEL S | Director | Option Exercise | A | 0.02 | 2,500,000 | 50,000 | 10,619,716 | |
| Mar 14 2014 | BHRT | U.S. Stem Cell, In ... | AHN SAMUEL S | Director | Buy | P | 0.01 | 8,771,929 | 122,807 | 22,862,091 | 14.1 M to 22.9 M (+62.26 %) |
| Mar 14 2014 | BHRT | U.S. Stem Cell, In ... | AHN SAMUEL S | Director | Buy | P | 0.03 | 2,500,000 | 75,000 | 14,090,162 | 11.6 M to 14.1 M (+21.57 %) |
| Mar 10 2014 | BHRT | U.S. Stem Cell, In ... | TOMAS MIKE | CEO & President | Option Exercise | A | 0.02 | 400,000 | 8,000 | 13,900,000 | |
| Mar 10 2014 | BHRT | U.S. Stem Cell, In ... | TOMAS MIKE | CEO & President | Option Exercise | A | 0.02 | 10,000,000 | 200,000 | 13,500,000 | |
| Mar 10 2014 | BHRT | U.S. Stem Cell, In ... | TOMAS MIKE | CEO & President | Option Exercise | A | 0.02 | 2,000,000 | 40,000 | 3,500,000 | |
| Mar 10 2014 | BHRT | U.S. Stem Cell, In ... | TOMAS MIKE | CEO & President | Buy | J | 0.01 | 6,578,947 | 92,105 | 6,578,947 | 0 to 6.6 M |
| Dec 31 2013 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Option Exercise | D | 0.02 | 1,000,000 | 20,000 | 1,563,529 | |
| Dec 31 2013 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Option Exercise | A | 0.02 | 400,000 | 8,000 | 2,563,529 | |
| Dec 31 2013 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Option Exercise | A | 0.06 | 1,666,670 | 100,000 | 2,163,529 | |
| Dec 31 2013 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | J | 0.01 | 8,771,929 | 122,807 | 8,771,929 | 0 to 8.8 M |
| Dec 31 2013 | BHRT | U.S. Stem Cell, In ... | Hart Charles A | Director | Option Exercise | A | 0.02 | 400,000 | 8,000 | 6,512,440 | |
| Dec 31 2013 | BHRT | U.S. Stem Cell, In ... | Hart Charles A | Director | Buy | J | 0.01 | 1,995,614 | 27,939 | 9,150,094 | 7.2 M to 9.2 M (+27.89 %) |
| Dec 31 2013 | BHRT | U.S. Stem Cell, In ... | Comella Kristin C | Chief Science Offic ... | Option Exercise | A | 0.02 | 5,000,000 | 100,000 | 5,562,288 | |
| Dec 31 2013 | BHRT | U.S. Stem Cell, In ... | Comella Kristin C | Chief Science Offic ... | Option Exercise | A | 0.02 | 500,000 | 10,000 | 562,288 | |
| Dec 31 2013 | BHRT | U.S. Stem Cell, In ... | Borman Mark P | Director | Option Exercise | A | 0.02 | 400,000 | 8,000 | 610,000 | |
| Feb 10 2012 | BHRT | U.S. Stem Cell, In ... | Hart Charles A | Director | Option Exercise | A | 0.01 | 3,571,430 | 50,000 | 6,540,540 | |
| Feb 10 2012 | BHRT | U.S. Stem Cell, In ... | Hart Charles A | Director | Buy | P | 0.01 | 3,571,430 | 50,000 | 7,154,480 | 3.6 M to 7.2 M (+99.68 %) |
| Feb 03 2012 | BHRT | U.S. Stem Cell, In ... | AHN SAMUEL S | Director | Option Exercise | A | 0.02 | 5,500,000 | 110,000 | 8,398,035 | |
| Feb 03 2012 | BHRT | U.S. Stem Cell, In ... | AHN SAMUEL S | Director | Buy | P | 0.02 | 5,500,000 | 110,000 | 11,590,162 | 6.1 M to 11.6 M (+90.31 %) |
| Jan 20 2012 | BHRT | U.S. Stem Cell, In ... | TOMAS MIKE | CEO & President | Option Exercise | A | 0.10 | 500,000 | 50,000 | 1,500,000 | |
| Dec 07 2011 | BHRT | U.S. Stem Cell, In ... | AHN SAMUEL S | Director | Option Exercise | A | 0.06 | 542,100 | 32,526 | 2,898,035 | |
| Dec 07 2011 | BHRT | U.S. Stem Cell, In ... | AHN SAMUEL S | Director | Buy | P | 0.05 | 1,084,200 | 54,210 | 6,090,162 | 5 M to 6.1 M (+21.66 %) |
| Nov 14 2011 | BHRT | U.S. Stem Cell, In ... | AHN SAMUEL S | Director | Option Exercise | A | 0.05 | 1,250,000 | 62,500 | 2,355,935 | |
| Nov 14 2011 | BHRT | U.S. Stem Cell, In ... | AHN SAMUEL S | Director | Buy | P | 0.04 | 2,500,000 | 100,000 | 5,005,962 | 2.5 M to 5 M (+99.76 %) |
| Sep 13 2011 | BHRT | U.S. Stem Cell, In ... | Comella Kristin C | Chief Science Offic ... | Option Exercise | A | 0.10 | 250,000 | 25,000 | 362,286 | |
| Sep 02 2011 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Option Exercise | A | 0.07 | 300,000 | 21,000 | 433,534 | |
| Sep 02 2011 | BHRT | U.S. Stem Cell, In ... | SPENCER RICHARD III | Director | Option Exercise | A | 0.07 | 100,000 | 7,000 | 289,135 | |
| Sep 02 2011 | BHRT | U.S. Stem Cell, In ... | Leonhardt Howard J | Chief Technology Of ... | Option Exercise | A | 0.07 | 100,000 | 7,000 | 126,379 | |
| Sep 02 2011 | BHRT | U.S. Stem Cell, In ... | Borman Mark P | Director | Option Exercise | A | 0.07 | 150,000 | 10,500 | 210,000 | |
| Sep 02 2011 | BHRT | U.S. Stem Cell, In ... | CARSON BRUCE C | Director | Option Exercise | A | 0.07 | 100,000 | 7,000 | 350,912 | |
| Sep 02 2011 | BHRT | U.S. Stem Cell, In ... | Hart Charles A | Director | Option Exercise | A | 0.07 | 460,000 | 32,200 | 570,000 | |
| Sep 02 2011 | BHRT | U.S. Stem Cell, In ... | AHN SAMUEL S | Director | Option Exercise | A | 0.07 | 100,000 | 7,000 | 219,134 | |
| Aug 17 2011 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Option Exercise | A | 0.21 | 40,000 | 8,400 | 133,534 | |
| Aug 17 2011 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Option Exercise | A | 0.06 | 1,666,670 | 100,000 | 4,884,968 | |
| Aug 17 2011 | BHRT | U.S. Stem Cell, In ... | MURPHY WILLIAM P JR | Director | Buy | P | 0.06 | 1,666,670 | 100,000 | 8,130,734 | 6.5 M to 8.1 M (+25.78 %) |
| Aug 17 2011 | BHRT | U.S. Stem Cell, In ... | AHN SAMUEL S | Director | Option Exercise | A | 0.21 | 10,000 | 2,100 | 119,134 |